F.D.A. Approves Drug for Persistently Deadly Form of Lung Cancer

Health
By Gina Kolata from NYT Health https://ift.tt/OR8NjIG
via IFTTT Lung Cancer, Drugs (Pharmaceuticals), Clinical Trials The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda